Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature achieves ‘The Sunday Times Heathrow SME Export Track 100’ for the 2nd year running

We are delighted to announce that Sygnature Discovery has been placed No 65 in The Sunday Times Heathrow SME Export Track 100 published in the Business section of The Sunday Times on 15th May 2016. The listing reflects Sygnature’s continued advances in supporting the  global pharmaceutical industry with early stage drug discovery expertise.

Latest News

View All

New platform set to accelerate early-stage targeted…

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…

Sygnature Discovery deploys Iktos’ AI technology ‘Makya™’